Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS) SHH

28.53

-0.25(-0.87%)

Updated at December 05 01:29PM

Currency In CNY

Valuation

Market Cap8.8B
Enterprise Value7.35B
P/E Ratio174.56
PEG Ratio1.75
Price/Sales Ratio8.86
Price/Book Ratio3.52
Enterprise/Revenue8.15
Enterprise/EBITDA58.45

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.05
Operating Margin0.06

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue1.59B
Revenue/Share3.23
Gross Profit1.09B
EBITDA265.53M
Net Income100.35M
Diluted EPS0.22

Balance Sheet

Total Cash1.66B
Total Cash/Share3.65
Total Debt72.65M
Total Debt/Equity0.02
Current Ratio1.76
Book Value Per Share8.25

Price History

52-Week Change43.46
52-Week High30.32
52-Week Low18.45
Moving Average 50 Days25.62
Moving Average 200 Days24.37

Statistics

Average Volume10.89M
Shares Outstanding455.87M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor16983:10000
Last Split DateJanuary 24, 2007